Stakeholder Perspectives on Randomized Clinical Trials for Children With Poor-Prognosis Cancers

The agreed-upon workshop conclusions provide a basis for key considerations while undertaking future drug development activities for children with poor-prognosis cancers, ensuring that the needs and perspectives of all stakeholders are factored in from the outset.